3rd Quarter - Report — INFECTIOUS DISEASES SOCIETY OF AMERICA for INFECTIOUS DISEASES SOCIETY OF AMERICA (2011)

Firm

INFECTIOUS DISEASES SOCIETY OF AMERICA

Client

INFECTIOUS DISEASES SOCIETY OF AMERICA

Income

—

Expenses

$102,890

Expense method

C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Reimbursement for outpatient infusion therapy; physician payments; Medicaid and Medicare, including Medicare Prescription Drug Coverage; Average Sales Price; Competitive Acquisition Program; infection control; antimicrobial stewardship; and Healthcare Reform.

Lobbyist	Covered position, as disclosed
ROBERT J GUIDOS	V.P. Public Policy & Government Relations
AMANDA JEZEK New	Government Relations Director
KIMBERLY ANN MILLER	HIV Medicine Association Policy Officer
JASON SCULL	Sr. Program Officer of Practice & Payment Policy

Contacted: HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); SENATE; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS)

Medical/Disease Research/Clinical Labs MED

Medical liability; antimicrobial resistance research; infectious diseases product research and development; regulatory science; unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; and support for evidence-based decision making.

Lobbyist	Covered position, as disclosed
ROBERT J GUIDOS	V.P. Public Policy & Government Relations
AMANDA JEZEK New	Government Relations Director
KIMBERLY ANN MILLER	HIV Medicine Association Policy Officer

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE

Health Issues HCR

Infectious diseases; drug, diagnostics and vaccine research and development; antimicrobial resistance; antimicrobial stewardship; hospital-acquired infections; immunizations; pandemic influenza, public health security and biodefense; global infectious diseases; biomedical research, reauthorization of President's Emergency Plan for AIDS Relief (PEPFAR); Lyme disease and other infectious diseases issues; Ryan White reauthorization; Preservation of Antibiotics for Medical Treatment Act; Generating Antibiotic Incentives Now Act; Strategies to Address Antimicrobial Resistance (STAAR).

Lobbyist	Covered position, as disclosed
ROBERT J GUIDOS	V.P. Public Policy & Government Relations
AMANDA JEZEK New	Government Relations Director
LESLIE MCGORMAN	Program Officer for Public Health
KIMBERLY ANN MILLER	HIV Medicine Association Policy Officer

Contacted: HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); SENATE; Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC)

Budget/Appropriations BUD

Funding support for the Department of Health and Human Services, Office of the Biomedical Advanced Research and Development Authority, Centers for Disease Control and Prevention, National Institutes of Health, Health Resources & Services Administration, Food & Drug Administration and global programs for various infectious diseases related issues.

Lobbyist	Covered position, as disclosed
ROBERT J GUIDOS	V.P. Public Policy & Government Relations
AMANDA JEZEK New	Government Relations Director
LESLIE MCGORMAN	Program Officer for Public Health
KIMBERLY ANN MILLER	HIV Medicine Association Policy Officer

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); SENATE; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES

Affiliated organisations

Organisation	Location
HIV MEDICINE ASSOCIATION	Arlington, VA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.